315 related articles for article (PubMed ID: 24429550)
21. Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants.
Janér J; Lassus P; Haglund C; Paavonen K; Alitalo K; Andersson S
Am J Respir Crit Care Med; 2006 Aug; 174(3):326-30. PubMed ID: 16690974
[TBL] [Abstract][Full Text] [Related]
22. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A
J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor c/vascular endothelial growth factor receptor 3 signaling regulates chemokine gradients and lymphocyte migration from tissues to lymphatics.
Iwami D; Brinkman CC; Bromberg JS
Transplantation; 2015 Apr; 99(4):668-77. PubMed ID: 25606800
[TBL] [Abstract][Full Text] [Related]
24. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.
Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM
Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927
[TBL] [Abstract][Full Text] [Related]
25. Transgenic overexpression of interleukin-1β induces persistent lymphangiogenesis but not angiogenesis in mouse airways.
Baluk P; Hogmalm A; Bry M; Alitalo K; Bry K; McDonald DM
Am J Pathol; 2013 Apr; 182(4):1434-47. PubMed ID: 23391392
[TBL] [Abstract][Full Text] [Related]
26. Pneumonectomy case in a newborn with congenital pulmonary lymphangiectasia.
Hwang JH; Kim JH; Hwang JJ; Kim KS; Kim SY
J Korean Med Sci; 2014 Apr; 29(4):609-13. PubMed ID: 24753713
[TBL] [Abstract][Full Text] [Related]
27. Laboratory models for the investigation of lymphangiomatosis.
Rockson SG
Microvasc Res; 2014 Nov; 96():64-7. PubMed ID: 25173588
[TBL] [Abstract][Full Text] [Related]
28. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
Blacker HA; Orgeig S
J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
[TBL] [Abstract][Full Text] [Related]
29. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of multi-organ lymphangiectasia resulting from temporal deletion of calcitonin receptor-like receptor in adult mice.
Hoopes SL; Willcockson HH; Caron KM
PLoS One; 2012; 7(9):e45261. PubMed ID: 23028890
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
32. Lymphatic vessels assessment in feline mammary tumours.
Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
[TBL] [Abstract][Full Text] [Related]
33. Chronic inflammation, lymphangiogenesis, and effect of an anti-VEGFR therapy in a mouse model and in human patients with aspiration pneumonia.
Nihei M; Okazaki T; Ebihara S; Kobayashi M; Niu K; Gui P; Tamai T; Nukiwa T; Yamaya M; Kikuchi T; Nagatomi R; Ebihara T; Ichinose M
J Pathol; 2015 Mar; 235(4):632-45. PubMed ID: 25348279
[TBL] [Abstract][Full Text] [Related]
34. Molecular targeting of lymphatics for therapy.
Stacker SA; Hughes RA; Achen MG
Curr Pharm Des; 2004; 10(1):65-74. PubMed ID: 14754406
[TBL] [Abstract][Full Text] [Related]
35. Ginsenoside Rg1 enhances lymphatic transport of intrapulmonary silica via VEGF-C/VEGFR-3 signaling in silicotic rats.
Yu J; Mao L; Guan L; Zhang Y; Zhao J
Biochem Biophys Res Commun; 2016 Mar; 472(1):182-8. PubMed ID: 26920056
[TBL] [Abstract][Full Text] [Related]
36. VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.
Secker GA; Harvey NL
Dev Dyn; 2015 Mar; 244(3):323-31. PubMed ID: 25399804
[TBL] [Abstract][Full Text] [Related]
37. Imaging Lymphatics in Mouse Lungs.
Baluk P; McDonald DM
Methods Mol Biol; 2018; 1846():161-180. PubMed ID: 30242759
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.
Jach R; Dyduch G; Radon-Pokracka M; Przybylska P; Mika M; Dulinska-Litewka J; Zajac K; Huras H; Streb J; Stangel-Wojcikiewicz K; Dziadek O; Galarowicz B
Neuro Endocrinol Lett; 2011; 32(4):530-9. PubMed ID: 21876509
[TBL] [Abstract][Full Text] [Related]
39. Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
Kajiya K; Sawane M; Huggenberger R; Detmar M
J Invest Dermatol; 2009 May; 129(5):1292-8. PubMed ID: 19005491
[TBL] [Abstract][Full Text] [Related]
40. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.
Chung ES; Chauhan SK; Jin Y; Nakao S; Hafezi-Moghadam A; van Rooijen N; Zhang Q; Chen L; Dana R
Am J Pathol; 2009 Nov; 175(5):1984-92. PubMed ID: 19808642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
